{"id":"spiromax-budesonide-formoterol","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Oral thrush"},{"rate":"10-20%","effect":"Headache"},{"rate":"10-20%","effect":"Cough"},{"rate":"5-10%","effect":"Dysphonia"},{"rate":"5-10%","effect":"Muscle cramps"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Budesonide is a corticosteroid that reduces inflammation in the airways, while formoterol is a long-acting beta2-adrenergic receptor agonist that relaxes bronchial muscles to improve airflow.","oneSentence":"Spiromax Budesonide/formoterol is a combination of a corticosteroid and a long-acting beta2-adrenergic receptor agonist used to treat asthma and COPD.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:35:56.801Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Maintenance and relief of asthma symptoms"},{"name":"Maintenance treatment of COPD"}]},"trialDetails":[{"nctId":"NCT02062463","phase":"PHASE3","title":"Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2014-05-28","conditions":"Asthma","enrollment":485},{"nctId":"NCT01803555","phase":"PHASE3","title":"Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-07-04","conditions":"Asthma","enrollment":605},{"nctId":"NCT02384577","phase":"","title":"Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment","status":"COMPLETED","sponsor":"Teva Pharma GmbH","startDate":"2014-07","conditions":"Patient Satisfaction","enrollment":4034},{"nctId":"NCT02477397","phase":"PHASE3","title":"Symptom-driven Maintenance and Reliever Treatment to Prevent Exacerbations in COPD","status":"UNKNOWN","sponsor":"University Medical Center Groningen","startDate":"2015-05-01","conditions":"COPD","enrollment":201},{"nctId":"NCT02757209","phase":"NA","title":"Comparative Study on Usability of Inhaler Devices in Adults With Asthma or COPD","status":"COMPLETED","sponsor":"Consorzio Futuro in Ricerca","startDate":"2016-04","conditions":"Asthma, COPD","enrollment":84},{"nctId":"NCT02570425","phase":"NA","title":"Comparing Maintenance of Device Mastery With Turbohaler© vs. Spiromax© in Healthcare Professionals naïve to Both Devices","status":"COMPLETED","sponsor":"Research in Real-Life Ltd","startDate":"2014-07","conditions":"Asthma","enrollment":516}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"ARTHRALGIA"},{"count":1,"reaction":"ABDOMINAL PAIN"},{"count":1,"reaction":"ANGINA PECTORIS"},{"count":1,"reaction":"ANXIETY"},{"count":1,"reaction":"APPENDICITIS"},{"count":1,"reaction":"ASTHMA"},{"count":1,"reaction":"CARDIAC FAILURE"},{"count":1,"reaction":"CEREBROVASCULAR ACCIDENT"},{"count":1,"reaction":"COVID-19"},{"count":1,"reaction":"DISCOMFORT"}],"_approvalHistory":[],"publicationCount":23,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Spiromax® budesonide/formoterol"],"phase":"phase_3","status":"active","brandName":"Spiromax Budesonide/formoterol","genericName":"Spiromax Budesonide/formoterol","companyName":"University Medical Center Groningen","companyId":"university-medical-center-groningen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Spiromax Budesonide/formoterol is a combination of a corticosteroid and a long-acting beta2-adrenergic receptor agonist used to treat asthma and COPD. Used for Maintenance and relief of asthma symptoms, Maintenance treatment of COPD.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}